Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Dr. Reddy’s Laboratories signing of a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative prescription head lice product, Xeglyze™ Lotion. The exclusive rights for this product are applicable for the territories of the United States, Canada, India, Russia and the CIS, Australia, New Zealand and Venezuela.

    [adsense:336x280:8701650588]

  • Body maps develop early in life and may be integral for fostering infants' sense of their own bodies, as well as the ability to connect with and learn from other people, new research has found. Researchers at the University of Washington's Institute for Learning and Brain Sciences (I-LABS) are among the first scientists worldwide to study body maps in the infant brain.

  • A new study warns that some diabetes drugs can substantially increase the amount of fat inside our bones and risk of bone fractures. The study was published in the journal Endocrinology.

  • Researchers at Southern Medical University have discovered a molecule that can help clinicians predict survival time of people afflicted with gastric cancer, a significant health problem in developing countries which is typically associated with late-stage diagnosis and high mortality. The findings appeared in The American Journal of Pathology.

  • AstraZeneca, a global, innovation-driven biopharmaceutical business, and The University of Manchester, a member of the prestigious Russell Group of British universities collaborate to deliver personalised healthcare for cancer patients. The five-year agreement will see the organisations apply clinical trial bioinformatics to better identify the right cancer treatment for the right patient at the right time. As part of the collaboration, AstraZeneca will provide a total of £11.5 million.

Subscribe to Pharma News